Literature DB >> 7421421

Intercorrelations among plasma high density lipoprotein, obesity and triglycerides in a normal population.

M J Albrink, R M Krauss, F T Lindgrem, J von der Groeben, S Pan, P D Wood.   

Abstract

The interrelationships among fatness measures, plasma triglycerides and high density lipoproteins (HDL) were examined in 131 normal adult subjects: 38 men aged 27-46, 40 men aged 47-66, 29 women aged 27-46 and 24 women aged 47-66. None of the women were taking estrogens or oral contraceptive medication. The HDL concentration was subdivided into HDL2b, HDL2a and HDL3 by a computerized fitting of the total schlieren pattern to reference schlieren patterns. Anthropometric measures employed included skinfolds at 3 sites. 2 weight/height indices and 2 girth measurements. A high correlation was found among the various fatness measures. These measures were negatively correlated with total HDL, reflecting the negative correlation between fatness measures and HDL2 (as the sum of HDL2a and 2b). Fatness measures showed no relationship to HDL3. There was also an inverse correlation between triglyceride concentration and HDL2. No particular fatness measure was better than any other for demonstrating the inverse correlation with HDL but multiple correlations using all of the measures of obesity improved the correlations. Partial correlations controlling for fatness did not reduce any of the significant correlations between triglycerides and HDL2 to insignificance. The weak correlation between fatness and triglycerides was reduced to insignificance when controlled for HDL2.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7421421     DOI: 10.1007/bf02534017

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  28 in total

1.  INTERRELATIONSHIP BETWEEN SKINFOLD THICKNESS, SERUM LIPIDS AND BLOOD SUGAR IN NORMAL MEN.

Authors:  M J Albrink; J W Meigs
Journal:  Am J Clin Nutr       Date:  1964-11       Impact factor: 7.045

2.  Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.

Authors:  O D Mjos; O Faergeman; R L Hamilton; R J Havel
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

3.  Plasma high-density lipoprotein cholesterol level. Influence of risk factor intervention.

Authors:  S B Hulley; R Cohen; G Widdowson
Journal:  JAMA       Date:  1977-11-21       Impact factor: 56.272

4.  Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man.

Authors:  R J Havel; J P Kane; M L Kashyap
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

5.  Predicting coronary heart disease from body measurements of Framingham males.

Authors:  A Damon; S T Damon; H C Harpending; W B Kannel
Journal:  J Chronic Dis       Date:  1969-04

6.  H.D.L. cholesterol: the variable components.

Authors:  D W Anderson
Journal:  Lancet       Date:  1978-04-15       Impact factor: 79.321

7.  The distribution of body fat in relation to habitual activity.

Authors:  W J Brown; P R Jones
Journal:  Ann Hum Biol       Date:  1977-11       Impact factor: 1.533

8.  HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.

Authors:  W P Castelli; J T Doyle; T Gordon; C G Hames; M C Hjortland; S B Hulley; A Kagan; W J Zukel
Journal:  Circulation       Date:  1977-05       Impact factor: 29.690

9.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

10.  Interrelationships among subgroups of serum lipoproteins in normal human subjects.

Authors:  R M Krauss; F T Lindgren; R M Ray
Journal:  Clin Chim Acta       Date:  1980-07-01       Impact factor: 3.786

View more
  22 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  H N Ginsberg
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Evidence of linkage of HDL level variation to APOC3 in two samples with different ascertainment.

Authors:  France Gagnon; Gail P Jarvik; Arno G Motulsky; Samir S Deeb; John D Brunzell; Ellen M Wijsman
Journal:  Hum Genet       Date:  2003-08-29       Impact factor: 4.132

3.  No, the glycaemic target in the critically ill should not be < or = 6.1 mmol/l.

Authors:  J M Miles; M M McMahon; W L Isley
Journal:  Diabetologia       Date:  2007-12-20       Impact factor: 10.122

Review 4.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

5.  Characterization of high density lipoprotein binding to human adipocyte plasma membranes.

Authors:  B S Fong; P O Rodrigues; A M Salter; B P Yip; J P Despres; A Angel; R E Gregg
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

Review 6.  Triglycerides and coronary risk.

Authors:  J M Gaziano
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

7.  Morphometric variables related to metabolic profile in captive chimpanzees (Pan troglodytes).

Authors:  Marcia C R Andrade; Paul B Higgins; Vicki L Mattern; Melissa A De La Garza; Kathleen M Brasky; V Saroja Voruganti; Anthony G Comuzzie
Journal:  Comp Med       Date:  2011-10       Impact factor: 0.982

8.  Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

Authors:  A Fontbonne; E Eschwège; F Cambien; J L Richard; P Ducimetière; N Thibult; J M Warnet; J R Claude; G E Rosselin
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

9.  Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in syrian hamsters.

Authors:  I Hardardóttir; A H Moser; J Fuller; C Fielding; K Feingold; C Grünfeld
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Lipoprotein subfractions of runners and sedentary men.

Authors:  P T Williams; R M Krauss; P D Wood; F T Lindgren; C Giotas; K M Vranizan
Journal:  Metabolism       Date:  1986-01       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.